Today: 3 July 2026
China pauses Nvidia H200 AI chip orders as CES 2026 fuels data-center rush

China pauses Nvidia H200 AI chip orders as CES 2026 fuels data-center rush

BEIJING, January 8, 2026, 01:39 (GMT+8)

Beijing has asked some Chinese tech companies to halt orders for Nvidia’s H200, a high-end graphics processing unit used to train and run AI models, the Information reported, citing people familiar with the matter. The move came as China weighs whether — and on what terms — it will allow access to the chips, the report said. “China is committed to basing its national development on its own strengths,” said Liu Pengyu, a spokesperson for the Chinese Embassy in the United States. Reuters

The pause underlines how quickly AI hardware has become a bargaining chip in the wider U.S.-China tech fight, with export licences and domestic industrial policy now shaping who gets computing power and when. Nvidia CEO Jensen Huang told reporters this week he was not expecting a formal sign-off from Beijing: “It’s just going to be purchase orders.” Nvidia has said it is seeking U.S. export approvals, and has called for $500 billion in sales from its current Blackwell chips and the next-generation Vera Rubin line by the end of the year. Reuters

At CES in Las Vegas, Lenovo signalled how much urgency sits behind those chips, pitching a data-centre package with Nvidia that it said could cut AI deployments to “weeks.” Lenovo CEO Yang Yuanqing said the tie-up “sets a new benchmark for scalable AI factory design,” as the PC maker pushed an AI platform, new device concepts and a cross-device “Qira” system that can run across Lenovo and Motorola hardware. Reuters

Money is still chasing the buildout. Elon Musk’s xAI said it raised $20 billion in an upsized Series E round, topping its $15 billion target, with investors including Valor Equity Partners, StepStone Group, Fidelity Management & Research Company and the Qatar Investment Authority. Asked for comment, xAI replied: “Legacy Media Lies.” Reuters

Another bet landed on measurement rather than models. LMArena, the startup behind the “Chatbot Arena” style head-to-head tests of large language models — AI systems that generate text — said it raised $150 million at a $1.7 billion valuation, with Felicis and UC Investments co-leading. “To measure the real utility of AI, we need to put it in the hands of real users,” said co-founder and CEO Anastasios Angelopoulos. Reuters

Robots are pulling in deal money too. Mobileye said it would buy humanoid robotics startup Mentee Robotics for about $900 million, extending its self-driving technology into what it calls “embodied AI” — software that senses and acts through a physical machine. Tesla, Figure AI and Agility Robotics are among groups chasing two-legged robots for warehouses and factories, with Mobileye saying first proof-of-concept deployments are expected in 2026. Reuters

But the near-term risk is that policy moves outrun engineering plans. If Beijing hardens its stance on foreign chips — or if U.S. export approvals tighten again — cloud providers and AI labs could face gaps in supply, higher costs and delayed rollouts just as they lock in spending.

For now, markets will watch for any shift in Chinese guidance on H200 orders and for clearer timing on U.S. export licences. The next signal may be mundane: a purchase order that appears — or doesn’t.

Marcin Frąckiewicz is the founder and CEO of TS2 Space, a satellite communications company serving customers around the world. A graduate of the Warsaw School of Economics (SGH), he has more than two decades of experience in telecommunications, satellite services and technology ventures. He writes about satellite communications, space technology, artificial intelligence and the stock market, with a particular focus on technology companies, semiconductors, emerging industries and the trends shaping global innovation.

Stock Market Today

  • AbbVie Jumps 4%, Tops Apogee Buy Price After Earnings Beat
    July 2, 2026, 7:16 PM EDT. AbbVie Inc. finished up 3.99% at $261.07, a new 52-week high. The stock gained nearly $17.8 billion in market cap, putting it well above the $10.9 billion Apogee Therapeutics deal announced June 22. AbbVie closed above targets from RBC Capital, Investing.com and Google Finance. With Q2 earnings set for July 31, the rally puts the spotlight on analyst target hikes. J.P. Morgan and RBC Capital have backed the Apogee buy for its long-term growth, with the company saying the acquisition will add to EPS by 2032. AbbVie outpaced broader markets, which slipped slightly, as investors bet on the drugmaker's deal strategy.
Eli Lilly stock ends higher to start 2026 as traders eye JPM conference, earnings
Previous Story

Eli Lilly stock ends higher to start 2026 as traders eye JPM conference, earnings

Gold price slips, GLD stock falls as traders brace for Friday’s U.S. jobs report
Next Story

Gold price slips, GLD stock falls as traders brace for Friday’s U.S. jobs report

Go toTop